@article{aaf0c8d5fb554e6090da78908533e062,
title = "Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.",
abstract = "Recently, plasma soluble urokinase plasminogen activator receptor (suPAR) has gained interest as a marker of cardiovascular risk. suPAR is released through the cleavage of urokinase plasminogen activator receptor (uPAR), which is found in monocytes, activated T-lymphocytes and endothelial cells, all involved in atherosclerosis. suPAR levels have been well studied in plasma, but no studies have focused on suPAR in human atherosclerotic plaques. The aim of this study was to determine whether suPAR measured in the plaque is associated with symptomatic plaques and plaque inflammation.",
author = "Andreas Edsfeldt and Mihaela Nitulescu and Helena Grufman and Caitriona Gr{\"o}nberg and Ana Persson and Nilsson, {Marie MN} and Margaretha Persson and Harry Bj{\"o}rkbacka and Isabel Goncalves",
year = "2012",
doi = "10.1161/STROKEAHA.112.664094",
language = "English",
volume = "43",
pages = "3305--3312",
journal = "Stroke: a journal of cerebral circulation",
issn = "1524-4628",
publisher = "American Heart Association",
number = "12",
}